6 October 2021
CVS Group Plc
("CVS", the "Company" or the "Group")
Long Term Incentive Plan Awards & PDMR Dealing
CVS, one of the UK's leading providers of integrated veterinary services, announces that it has granted option awards over a total of 74,174 of the Company's ordinary shares of 0.2 pence each ("Ordinary Shares") under the CVS Group Long Term Incentive Plan 2021 ("LTIP 15") (the "Options"). As detailed below, certain of the Options were awarded to the Directors named below, with the balance being issued to certain other employees.
Options awarded to Directors
Name Role Number of Options
Richard Fairman Chief Executive Officer 21,188
Ben Jacklin Chief Operating Officer 12,712
Robin Alfonso Chief Financial Officer 11,009
The awards will vest in three years' time, subject to certain performance criteria being satisfied. These vesting criteria relate to the Company's earnings per share growth and total shareholder return over the three-year period between 1 July 2021 and 30 June 2024.
The notification below, made in accordance with the requirements of the UK Market Abuse Regulation, provides further detail.
|
|
|
|
CVS Group plc |
via MHP Communications |
|
Richard Fairman, CEO |
|
|
Jenny Farrer, Company Secretary |
|
|
Singer Capital Markets (Nominated Adviser & Broker) |
+44 20 7496 3000 |
|
Aubrey Powell / Jen Boorer / Rachel Hayes |
|
|
MHP Communications (Financial PR) |
+44 20 3128 8549 |
|
Andrew Jaques / Rachel Mann / Charles Hirst |
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|||||
|
a) |
Name |
Richard Fairman |
||||
|
2 |
Reason for the notification |
|||||
|
a) |
Position/status |
Chief Executive Officer |
||||
|
b) |
Initial notification /Amendment |
Initial Notification |
||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
|
a) |
Name |
CVS Group plc |
||||
|
b) |
LEI |
213800J41XDQ2NX48O05 |
||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Options over ordinary shares of 0.2 pence each GB00B2863827 |
||||
|
b) |
Nature of the transaction |
Grant of options under LTIP 15 |
||||
|
c) |
Price(s) and volume(s) |
|
||||
|
d) |
Aggregated information - Aggregated volume - Price |
N/A |
||||
|
e) |
Date of the transaction |
6 October 2021 |
||||
|
f) |
Place of the transaction |
Off market |
||||
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|||||
|
a) |
Name |
Ben Jacklin |
||||
|
2 |
Reason for the notification |
|||||
|
a) |
Position/status |
Chief Operating Officer |
||||
|
b) |
Initial notification /Amendment |
Initial Notification |
||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
|
a) |
Name |
CVS Group plc |
||||
|
b) |
LEI |
213800J41XDQ2NX48O05 |
||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Options over ordinary shares of 0.2 pence each GB00B2863827 |
||||
|
b) |
Nature of the transaction |
Grant of options under LTIP 15 |
||||
|
c) |
Price(s) and volume(s) |
|
||||
|
d) |
Aggregated information - Aggregated volume - Price |
N/A |
||||
|
e) |
Date of the transaction |
6 October 2021 |
||||
|
f) |
Place of the transaction |
Off market |
||||
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
||||||
|
a) |
Name |
Robin Alfonso |
|||||
|
2 |
Reason for the notification |
||||||
|
a) |
Position/status |
Chief Financial Officer |
|||||
|
b) |
Initial notification /Amendment |
Initial Notification |
|||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||||
|
a) |
Name |
CVS Group plc |
|||||
|
b) |
LEI |
213800J41XDQ2NX48O05 |
|||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Options over ordinary shares of 0.2 pence each GB00B2863827 |
|||||
|
b) |
Nature of the transaction |
Grant of options under LTIP 15 |
|||||
|
c) |
Price(s) and volume(s) |
|
|||||
|
d) |
Aggregated information - Aggregated volume - Price |
N/A |
|||||
|
e) |
Date of the transaction |
6 October 2021 |
|||||
|
f) |
Place of the transaction |
Off market |
|||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.